Abstract
Chronic inflammation stimulates of neovascularization. The aim of this study was to evaluate the effect of sera from interstitial lung diseases (ILD) patients on angiogenic capabilities of different subsets of mononuclear cells. Serum samples were obtained from 22 patients with sarcoidosis, 20 with hypersensitivity pneumonitis, 20 with idiopathic pulmonary fibrosis, 9 with systemic sclerosis, 6 with pulmonary Langerhans cells histiocytosis, and from 20 healthy volunteers. Animal model of leukocyte induced angiogenesis assay was used as an angiogenic test. The pattern of angiogenic reaction was different in different diseases. Sera from systemic sclerosis and pulmonary Langerhans cells histiocytosis patients exerted inhibitory effects on angiogenesis, but sera from sarcoidosis, hypersensitivity pneumonitis, and idiopathic pulmonary fibrosis patients stimulated angiogenesis. Sera from sarcoidosis and pulmonary Langerhans cells histiocytosis primed monocytes for the production of angiogenic factors. The number of microvessels created after incubation of mononuclear cells depleted of monocytes with sera from systemic sclerosis patients significantly decreased. We conclude that the role of monocytes in the modulation of angiogenesis varies depending on the type of ILD. Sera from sarcoidosis stimulate and from pulmonary Langerhans cells histiocytosis patients inhibit neovascularization induced by monocyte mediators. Sera from systemic sclerosis inhibit angiogenesis induced by lymphocyte products.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Antoniou, K. M., Tzouvelekis, A., Alexandrakis, M. G., Sfiridaki, K., Tsiligianni, I., Rachiotis, G., Tzanakis, N., Bouros, D., Milic-Emili, J., & Siafakas, N. M. (2006). Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest, 130(4), 982–988.
ARA. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. (1980). Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis and Rheumatism, 23(5), 581–590.
ATS/ERS. (2002). International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine, 165(3), 277–304.
Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407(6801), 249–257.
Ebina, M., Shimizukawa, M., Shibata, N., Kimura, Y., Suzuki, T., Endo, M., Sasano, H., Kondo, T., & Nukiwa, T. (2004). Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 169(11), 1203–1208.
Girard, M., Israël-Assayag, E., & Cormier, Y. (2004). Pathogenesis of hypersensitivity pneumonitis. Current Opinion in Allergy and Clinical Immunology, 4(2), 93–98.
Griffioen, A. W., & Molema, G. (2000). Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacological Reviews, 52(2), 237–268.
Herrick, A. L. (2000). Vascular function in systemic sclerosis. Current Opinion in Rheumatology, 12(6), 527–533.
Hirshoren, N., Neuman, T., Gross, M., & Eliashar, R. (2010). Angiogenesis in chronic rhinosinusitis with nasal polyps and in antrochoanal polyps. Inflammation Research, 60(4), 321–327.
Hunninghake, G. W., Costabel, U., Ando, M., Baughman, R., Cordier, J. F., du Bois, R., Eklund, A., Kitaichi, M., Lynch, J., Rizzato, G., Rose, C., Selroos, O., Semenzato, G., & Sharma, O. P. (1999). ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 16(2), 149–173.
Kambouchner, M., Basset, F., Marchal, J., Uhl, J. F., Hance, A. J., & Soler, P. (2002). Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. American Journal of Respiratory and Critical Care Medicine, 166(11), 1483–1490.
Keane, M. P., & Strieter, R. M. (2002). The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease. Respiratory Research, 3(1), 5–11.
Keane, M. P., Arenberg, D. A., Lynch, J. P., 3rd, Whyte, R. I., Iannettoni, M. D., Burdick, M. D., Wilke, C. A., Morris, S. B., Glass, M. C., DiGiovine, B., Kunkel, S. L., & Strieter, R. M. (1997). The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. The Journal of Immunology, 159(3), 1437–1443.
Keane, M. P., Belperio, J. A., Burdick, M. D., Lynch, J. P., Fishbein, M. C., & Strieter, R. M. (2001). ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 164(12), 2239–2242.
Lingen, M. W. (2001). Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Archives of Pathology & Laboratory Medicine, 125(1), 67–71.
Lynch, J. P., 3rd, Standiford, T. J., Rolfe, M. W., Kunkel, S. L., & Strieter, R. M. (1992). Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. The American Review of Respiratory Disease, 145(6), 1433–1439.
Mackiewicz, Z., Sukura, A., Povilenaité, D., Ceponis, A., Virtanen, I., Hukkanen, M., & Konttinen, Y. T. (2002). Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clinical and Experimental Rheumatology, 20(5), 641–646.
Majewski, S., Skopinska-Rozewska, E., Jablonska, S., Polakowski, I., Pawinska, M., Marczak, M., & Szmurlo, A. (1985). Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis. Arthritis and Rheumatism, 28(10), 1133–1139.
Meyer, K. C., Kaminski, M. J., Calhoun, W. J., & Auerbach, R. (1989). Studies of bronchoalveolar lavage cells and fluids in pulmonary sarcoidosis. I Enhanced capacity of bronchoalveolar lavage cells from patients with pulmonary sarcoidosis to induce angiogenesis in vivo. The American Review of Respiratory Disease, 140(5), 1446–1449.
Navarro, C., Ruiz, V., Gaxiola, M., Carrillo, G., & Selman, M. (2003). Angiogenesis in hypersensitivity pneumonitis. Archives of Physiology and Biochemistry, 111(4), 365–368.
Okabe, T., & Takaku, F. (1986). A macrophage factor that stimulates the proliferation of vascular endothelial cells. Biochemical and Biophysical Research Communications, 134(1), 344–350.
Pepper, M. S., Mandriota, S. J., Vassalli, J. D., Orci, L., & Montesano, R. (1996). Angiogenesis-regulating cytokines: Activities and interactions. Current Topics in Microbiology and Immunology, 213(Pt 2), 31–67.
Renzoni, E. A., Walsh, D. A., Salmon, M., Wells, A. U., Sestini, P., Nicholson, A. G., Veeraraghavan, S., Bishop, A. E., Romanska, H. M., Pantelidis, P., Black, C. M., & Du Bois, R. M. (2003). Interstitial vascularity in fibrosing alveolitis. American Journal of Respiratory and Critical Care Medicine, 167(3), 438–443.
Semenza, G. L. (2007). Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling. Journal of Cellular Biochemistry, 102(4), 840–847.
Sidky, Y. A., & Auerbach, R. (1975). Lymphocyte-induced angiogenesis: A quantitative and sensitive assay for the graft-versus-host reaction. The Journal of Experimental Medicine, 141(5), 1084–1101.
Simler, N. R., Brenchley, P. E., & Horrocks, A. W. (2004). Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax, 59(7), 581–585.
Tolnay, E., Kuhnen, C., Voss, B., Wiethege, T., & Müller, K. M. (1998). Expression and localization of vascular endothelial growth factor and its receptor fit in pulmonary sarcoidosis. Virchows Archiv, 432(1), 61–65.
Uebelhoer, M., Bewig, B., Sternberg, K., Rabe, K., Nowak, D., Magnussen, H., & Barth, J. (1995). Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: Determination of phenotypic and functional changes. Lung, 173(3), 187–195.
Yamaguchi, N., Anand-Apte, B., Lee, M., Sasaki, T., Fukai, N., Shapiro, R., Que, I., Lowik, C., Timpl, R., & Olsen, B. R. (1999). Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. The EMBO Journal, 18(16), 4414–4423.
Zielonka, T. M., Demkow, U., Filewska, M., Radzikowska, E., Bialas, B., Korczynski, P., Szopiński, J., Soszka, A., & Skopinska-Rozewska, E. (2007). Angiogenic activity of sera from interstitial lung diseases patients to IL-6, IL-8, IL-12 and TNFα serum level. Central European Journal of Immunology, 32(1), 53–60.
Zielonka, T. M., Demkow, U., Filewska, M., Bialas, B., Zycinska, K., Radzikowska, E., Wardyn, A. K., & Skopinska-Rozewska, E. (2010). Angiogenic activity of sera from extrinsic allergic alveolitis patients in relation to clinical, radiological, and functional pulmonary changes. Lung, 188(5), 375–380.
Acknowledgments
Supported by an internal grant of the Institute of Tuberculosis and Lung Diseases in Warsaw.
Conflicts of interest: No conflict of interest was declared with relation to this work.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Zielonka, T.M. et al. (2013). Influence of Sera from Interstitial Lung Disease Patients on Angiogenic Activity of Mononuclear Cells. In: Pokorski, M. (eds) Respiratory Regulation - The Molecular Approach. Advances in Experimental Medicine and Biology, vol 756. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4549-0_18
Download citation
DOI: https://doi.org/10.1007/978-94-007-4549-0_18
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4548-3
Online ISBN: 978-94-007-4549-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)